Calidi Biotherapeutics GAAP EPS of -$1.99

2 hours ago 1

Calidi Biotherapeutics press release (NYSE:CLDI): Q2 GAAP EPS of -$1.99.
The company had approximately $5.3 million in cash and $0.1 million in restricted cash as of June 30, 2025, compared to $9.6 million in cash and $0.2 million in restricted cash as of December 31, 2024.

Recommended For You